Azacitidin Viatris 100 mg, Pulver zur Herstellung einer Injektionssuspension

7680676760021 CH-67676 Pulver zur Herstellung einer Injektionssuspension
Azacitidin Viatris 100 mg, Pulver zur Herstellung einer Injektionssuspension
Azacitidin Viatris 100 mg, Pulver zur Herstellung einer Injektionssuspension
Azacitidin Viatris 100 mg, Pulver zur Herstellung einer Injektionssuspension
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Pulver zur Herstellung einer Injektionssuspension
Galenic group
Lösbar zur Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
06/12/2024
Summary of Product Characteristics
Français
06/12/2024
Summary of Product Characteristics
Italien
06/12/2024

Detailed composition

Substance Quantity Type Category
(N/A)
100.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 259.95
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/05/2021

Authorization holder

Viatris Pharma GmbH

6312 Steinhausen

Authorization information

Swissmedic authorization number
67676
Drug name
Azacitidin Viatris, Pulver zur Herstellung einer Injektionssuspension
Galenic form
PULVS
ATC Code
L01BC07
Authorization status
Z
Dispensing category
A
First authorization
18/01/2021
Authorization expiration date
31/12/9999
IT Number
07.16.1.
Domain
Human medicine
Field of application
Zytostatikum

Package details

Description (FR)
AZACITIDIN Viatris subst sèche 100 mg flac
Description (DE)
AZACITIDIN Viatris Trockensub 100 mg Durchstf
Market launch
18/01/2021
Narcotic (BTM)
No

Original drug

Vidaza, Lyophilisat zur Herstellung einer Injektionssuspension
GTIN: 7680573800011
CHF 350.75
View original

Other package sizes (1)

AZACITIDIN Mylan subst sèche 100 mg flac
None None
GTIN: 7680676760014
Not in V1